John Matthei - Athenex Chief Officer

Insider

John Matthei is Chief Officer of Athenex
Phone716 427-2950
Webwww.athenex.com

Athenex Management Efficiency

The company has return on total asset (ROA) of (0.1965) % which means that it has lost $0.1965 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (19.2727) %, meaning that it created substantial loss on money invested by shareholders. Athenex's management efficiency ratios could be used to measure how well Athenex manages its routine affairs as well as how well it operates its assets and liabilities.
Athenex currently holds 42.36 M in liabilities with Debt to Equity (D/E) ratio of 4.58, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Athenex has a current ratio of 1.28, suggesting that it is in a questionable position to pay out its financial obligations when due. Note, when we think about Athenex's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 9 records

INSIDER Age

Hoyoung MDCytomX Therapeutics
56
Jamie MooreCytomX Therapeutics
N/A
Jim WangAdverum Biotechnologies
N/A
Brigit RileyAdverum Biotechnologies
46
Kishor JDAdverum Biotechnologies
54
MBA BSCytomX Therapeutics
46
Nancy PecotaAdverum Biotechnologies
64
Christopher OgdenCytomX Therapeutics
41
DPHIL DPhilCytomX Therapeutics
57
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. Athenex, Inc. was incorporated in 2003 and is headquartered in Buffalo, New York. Athenex operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 652 people. Athenex (ATNX) is traded on NASDAQ Exchange in USA and employs 269 people.

Management Performance

Athenex Leadership Team

Elected by the shareholders, the Athenex's board of directors comprises two types of representatives: Athenex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Athenex. The board's role is to monitor Athenex's management team and ensure that shareholders' interests are well served. Athenex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Athenex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Allen Barnett, CoFounder Emeritus
Daniel MD, Pres Therapy
Jeffrey Yordon, COO and President Athenex Pharmaceutical Division
John Matthei, Chief Officer
Jacqueline Li, VP Devel
Caileigh Dougherty, Director Relations
Joe CFA, Chief Officer
BS MB, Chief Officer
FRCP MBBS, Chairman CEO
Steven Adams, Chief Officer

Athenex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Athenex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Athenex Stock

If you are still planning to invest in Athenex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Athenex's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Correlations
Find global opportunities by holding instruments from different markets